INTRODUCTION
In the history of medicine, there are several evidences pointing out to diabetes related foot diseases and its treatment in the past. There is evidence from the mummies of Ramses II, that there existed calcific atherosclerosis in the leg vessels around 1200 BC. There is also evidence of treatment i.e. cutting away the mortified parts for gangrene foot in Hippocrates text. In the Book of Kings from Bible, there is reference to King Asa who became diseased in his feet and slept with his fore fathers which is speculated by some as the first recorded case of diabetic gangrene of foot in poorly controlled Type II diabetes. 1 WHO describes that the foot of a diabetic has potential risk of pathologic consequences like infection, ulceration, destruction of deep tissues associated with or without peripheral neuropathy, and or various degrees of peripheral vascular disease with metabolic complications of diabetes.
PAD is manifestation of atherosclerosis characterized by atherosclerotic occlusive disease of the lower extremities. The prevalence of peripheral vascular disease has been difficult to estimate and is around 13-45% in various studies. Framingham heart study revealed that 20% of symptomatic patients with PAD had diabetes but this probably underestimates the prevalence as most people with PAD are asymptomatic. 2 Diabetes, smoking, hypertension, advanced age, hyperlipidemia, elevated Creactive protein, apolipoprotein, lipoprotein (a), fibrinogen and plasma viscosity are the risk factors for PAD. 3 The mechanisms by which diabetes induces atherosclerosis are multifactorial and include inflammatory processes, derangements of various cell types within the vascular wall, promotion of coagulation, and inhibition of fibrinolysis. These factors both increase the susceptibility of the vasculature to atherosclerosis, as well as the instability that makes plaque prone to rupture and thrombosis. Thus, it is important to use a multidisciplinary approach to improve the clinical outcomes in this patient population. Diabetes is most strongly associated with femoro-popliteal and tibial occlusion i.e., below the knee PAD whereas smoking and hypertension are associated with more proximal disease in the aorto-ilio-femoral vessels.
Diagnosing PAD early is very crucial, because it can reduce the functional disability and limb loss. Also, very importantly it can identify a patient who is at high risk of developing a myocardial infarction or stroke. 4 Though the most common symptom of PAD without sensory neuropathy is intermittent claudication, it can also present late with rest pain, ulcer in foot and gangrene of toe, foot or the entire leg.
Critical limb ischemia (CLI) is a collective term including chronic ischemic rest pain, ulcers or gangrene attributable to objectively proven arterial occlusive disease. 5 On the other hand, patients with peripheral neuropathy will elicit subtle symptoms of slow walking velocity and easy leg fatiguability which they usually attribute to getting older. Hence most of these diabetics experience worst kind of lower limb dysfunction at a later date as they are prone to develop suddden ischaemia of their lower limb due to arterial thrombosis. 5, 6 Clinical examination includes
• Palpation of peripheral pulses -absence of two or more pulses on both the feet is diagnostic of peripheral vascular disease 7 • Measurement of ankle brachial index.
Aim of the study was to study the prevalence of peripheral arterial disease (PAD) in diabetic foot, to study the average age of presentation of PAD in diabetics, to study its prevalence in male and female, to study the level of arterial occlusions in PAD associated diabetic foot, to study the implications of socioeconomic status in PAD with diabetic foot, to study the outcome of diabetic foot patients with PAD, to study the prevalence of coronary artery disease and cerebrovascular accidents in diabetic patients with PAD. Patient's data were collected using a proforma based on factors such as age, sex and socioeconomic status were noted. History such as foot ulcer with its duration, presence of pain and its duration, numbness, discolouration, joint mobility, trauma were recorded. Duration and treatment of diabetes, family history of diabetes, previous history of surgery (amputations/disarticulations) were also recorded.
METHODS

Patients admitted and seen in OP for
Physical examination was done to note site and size of ulcer, presence or absence of discharge; peripheral pulsation; sensation to touch, pain and temperature; vibration perception and joint mobility. X-ray foot, doppler and ankle brachial index (ABI) were taken. Follow up was done with physical examination, doppler and ABI once in every month for a minimum of 2 months.
RESULTS
The study conducted in our institution from January 2013 to October 2013 showed the following results.
The high prevalence of PAD is often under estimated. As some patients in the study were asymptomatic, subclinical PAD is often missed. But with the use of ankle brachial index and Doppler even the subclinical cases were picked up in our study. Our study demonstrated a prevalence of 38% i.e., 57 patients out of 150 patients had PAD associated with diabetic foot. Prevalence of PAD according to the duration of diabetes is maximum between 1-10 years with a prevalence of 16% (24 cases out of 150), closely followed with a 14 % prevalence (21 cases out of 150) in the duration of diabetes between 11-20 years. Our study reported a higher prevalence of PAD in males with diabetic foot with an incidence of 22% compared to an incidence of 16% in females.
Our study reported that around 11 patients (37%) with PAD and diabetic foot had occlusion in the femoropopliteal segment followed by tibial occlusion noted in 8 patients (27%). Amputations and disarticulations have higher frequency (49.12%) than revascularisations (12.28%) for PAD associated diabetic foot.
Around 12 patients (42.85%) underwent amputation at the level of the toe followed by 9 patients (32.14%) who underwent below knee amputation. Around 28 diabetic foot patients (49.12%) with PAD underwent amputation compared to 9 diabetic foot patients (9.6%) without PAD. Higher rate of amputation was noted in diabetic foot patients with PAD. CAD and CVA are significantly increased in diabetic foot patients with PAD. In this study, associated CVA/CAD was noted in 11 patients out of 57 diabetic foot patients with PAD. The incidence of associated CVA/CAD was 19.29 % in diabetic foot patients with PAD compared to 7.52% in diabetic foot patients without PAD.
DISCUSSION
Diabetic foot related problems is increasing steadily in India owing to the high prevalence of diabetes mellitus in India. With a prevalence of 65.1 million, which is more than 7.1% of the adult population, India holds the second place in the world.
It is clear from the study that it has been difficult to estimate the prevalence of PAD in patients with diabetes, because the presentation is varied, from numbness due to neuropathy to claudicating pain, ulcer and gangrene. The prevalence of PAD increases with advancing age and is 3.2% below 50 years of age and rises to 55% in those above 80 years of age. 9 Similarly it also increases with increased duration of diabetes, 15% at 10 years and 45% after 20 years. 10 Our study has given a prevalence of 38% when compared to Marinelli et al (33%) and Migdalis et al (44%) which have given a prevalence of 33% and 44% respectively. i.e., 57 patients out of 150 patients had PAD associated with diabetic foot. PAD according to the duration of diabetes is maximum between 1 and 10 years with a prevalence of 16% (24 cases out of 150), closely followed by 11-20 years duration with 14% prevalence (21 cases out of 150). But in comparison, various studies have shown steady and a significant rise in prevalence of PAD with duration of diabetes. 11 This can be attributed to the small study group of 150 cases and cases reported in 11-20 years duration and 21 -30 years duration were only 19 and 17 respectively. On analyzing the prevalence of PAD in diabetic foot patients according to sex, from my study it is higher in males (22%) than in females (16%). While comparing with other studies, the result of my study is comparable to rest with higher incidence in males than in females. 12 This also correlates with the existing data that male sex has a higher prevalence of PAD in diabetic foot. Many patients for whom amputations were done had stage 4 PVD (late presentation) and had superadded infection. Also since most of our patients are from low socio economic status (lower middle, upper lower and lower), their knowledge of the disease was low and hence presented late. Most of the amputations are minor (toe and foot) which is similar to that of Zagreb study but with slight higher percentage (57.53 % versus 70.08 %) because the level of occlusion is highest at femoro-popliteal and tibial vessels according to our study. Above knee amputations are performed in much higher rate in our institution when compared to Zagreb study.
The prevalence of PAD according to socioeconomic status shows higher rate in lower socio economic groups. This finding could be substantiated by the fact that risk factors like smoking and diabetes is higher in lower socio economic groups. A population based study by Kroger K et al and Monica G et al study has also concluded that PAD is more prevalent in lower socio economic groups. Also, additional behavioral risk factors such as awareness to health or adherence to treatment can be attributed to increased prevalence of PAD in diabetic foot.
CONCLUSION
• The prevalence of peripheral artery disease in patients with diabetic foot is significantly high i.e. 38% as per this study. All patients may not be symptomatic or show obvious signs of PVD, but there is a need for properly investigating them.
• Males have a higher predilection for developing peripheral vascular disease than females.
• The older the individual, the higher are the chances of having peripheral vascular compromise. The average age of presentation of PAD in diabetics is 40-60 years.
• The most common level of arterial occlusion in PAD associated diabetic foot is femoro-popliteal segment followed by tibial segment.
• PAD influences the outcome of diabetic foot ulcers significantly with higher rate of amputations in PAD patients.
• CAD and CVA are significantly increased in diabetic foot patients with PAD and hence PAD is a marker of systemic vascular disease involving coronary and cerebral vessels, like myocardial infarction (MI), stroke and death.
• The prevalence of PAD is higher in lower socioeconomic status group.
• This study and others in the past have consistently proved the benefits and need of investigating diabetics for peripheral vascular disease through clinical palpation for peripheral pulses and ankle brachial index. The use of Arterial Doppler along with clinical methods can be of great significance in the proper evaluation and appropriate management of these individuals.
